| Azd4547 | IC50 | 103.0 [1] |
| N-[2-[[6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]-3-methylphenyl]prop-2-enamide | IC50 | 14.0 [1] |
| Infigratinib | IC50 | 0.82 [1], 60.0 [2], 62.0 [3], 64.0 [4], 71.0 [5] |
| 2-Formyl-N-[5-(trifluoromethyl)pyridin-2-yl]quinoline-8-carboxamide | IC50 | 57.0 [1] |
| (1S,2S,3R,4R)-3-[[5-Cyano-2-[4-[4-(dimethylamino)piperidin-1-yl]-2-(2-methylpropoxy)anilino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide | IC50 | 6.9 [1] |
| N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-2-(prop-2-enoylamino)benzamide | IC50 | 0.8 [1], 1.5 [2], 3.6 [3], 443.0 [4] |
| 6-Chloro-N-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-3-nitropyridin-2-amine | IC50 | 21.0 [1], 32.0 [2], 53.0 [3], 10000.0 [4] |
| Nvp-tae 684 | IC50 | 16.0 [1], 20.0 [2], 1920.0 [3] |
| N-[3-[[3-(2,6-Dichloro-3,5-dimethoxyphenyl)-7-[4-(diethylamino)butylamino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]methyl]phenyl]prop-2-enamide | IC50 | 189.0 [1], 261.0 [2], 261.3 [3] |
| N-(5-Cyano-4-methoxypyridin-2-yl)-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 6.3 [1], 72.0 [2] |
| N-[5-Cyano-4-(2-methoxyethoxy)pyridin-2-yl]-2-formyl-5,6,7,8-tetrahydropyrido[2,3-b]azepine-9-carboxamide | IC50 | 175.0 [1], 741.0 [2] |
| N-(5-Chloropyridin-2-yl)-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 21.0 [1], 916.0 [2] |
| N-[5-Cyano-4-[2-(dimethylamino)ethoxy]pyridin-2-yl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 10.6 [1], 11.0 [2], 588.0 [3] |
| N-(5-Cyanopyrimidin-2-yl)-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 45.0 [1], 131.0 [2] |
| N-(5-Cyanopyridin-2-yl)-2-formyl-5,6,7,8-tetrahydropyrido[2,3-b]azepine-9-carboxamide | IC50 | 660.0 [1], 3000.0 [2] |
| 6-Formyl-N-[5-(trifluoromethyl)pyridin-2-yl]-2,3-dihydropyrido[3,2-b][1,4]oxazine-4-carboxamide | IC50 | 42.0 [1], 531.0 [2] |
| N-(5-Cyano-4-morpholin-4-ylpyridin-2-yl)-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 27.0 [1], 224.0 [2] |
| N-[5-Cyano-4-(4-hydroxy-4-methylpiperidin-1-yl)pyridin-2-yl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 1.2 [1], 24.0 [2] |
| N-[5-Cyano-4-(2-methoxyethoxy)pyridin-2-yl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 1.3 [1], 18.0 [2] |
| N-(5-Cyano-4-propan-2-yloxypyridin-2-yl)-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 0.7 [1], 29.0 [2] |
| N-(5-Cyanopyridin-2-yl)-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 15.8 [1], 16.0 [2], 108.0 [3] |
| 7-Formyl-N-(6-methoxypyrimidin-4-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 140.0 [1], 3000.0 [2] |
| N-(5-Cyano-4-propan-2-yloxypyridin-2-yl)-6-formyl-2,3-dihydropyrrolo[2,3-b]pyridine-1-carboxamide | IC50 | 1.1 [1], 55.0 [2] |
| N-[5-Cyano-4-(oxan-4-yl)pyridin-2-yl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 17.0 [1], 150.0 [2] |
| B-Cell Immunosuppressant | IC50 | 10000.0 [1] |
| 8-[[5-(Trifluoromethyl)pyridin-2-yl]carbamoyl]quinoline-2-carboxylic acid | IC50 | 10000.0 [1] |
| 2-(Hydroxymethyl)-N-[5-(trifluoromethyl)pyridin-2-yl]quinoline-8-carboxamide | IC50 | 10000.0 [1] |
| 2-Formyl-N-[4-(trifluoromethyl)phenyl]quinoline-8-carboxamide | IC50 | 10000.0 [1] |
| Debio-1347 | IC50 | 290.0 [1] |
| H3B-6527 | IC50 | 0.2 [1], 1.0 [2] |
| N-[2-[[5-[(2,6-Dichloro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-3-methylphenyl]prop-2-enamide | IC50 | 4.0 [1], 11.1 [2] |
| 7-Formyl-N-[5-(trifluoromethyl)pyridin-2-yl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 13.0 [1], 13.3 [2] |
| 7-Formyl-N-pyridin-2-yl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 300.0 [1] |
| N-(5-Cyanopyrazin-2-yl)-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 33.0 [1] |
| 2-[4-[6-Chloro-2-[4-(4-methylpiperazin-1-yl)phenyl]-1H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]-N-(1,3-thiazol-2-yl)acetamide | IC50 | 20.0 [1], 130.0 [2] |
| 3-[5-Cyano-4-(2-methoxyethylamino)pyridin-2-yl]-1-(6-formylpyridin-2-yl)-1-methylurea | IC50 | 6.5 [1], 41.0 [2] |
| 3-[5-Cyano-4-(2-methoxyethylamino)pyridin-2-yl]-1-(6-formylpyridin-2-yl)-1-(2-methoxyethyl)urea | IC50 | 7.4 [1], 91.0 [2] |
| N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 23.0 [1], 2800.0 [2] |
| 7-Formyl-N-(5-methyl-1H-pyrazol-3-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | IC50 | 790.0 [1], 3000.0 [2] |
| N-(5-Cyano-4-propan-2-yloxypyridin-2-yl)-6-formylpyrrolo[2,3-b]pyridine-1-carboxamide | IC50 | 3.2 [1], 750.0 [2] |
| Infigratinib phosphate | IC50 | 60.0 [1], 168.0 [2] |
| 4-N-(3,5-Dimethoxyphenyl)-4-N-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-1-N-propan-2-ylcyclohexane-1,4-diamine | IC50 | 6.76 [1], 25.12 [2] |
| Staurosporine | IC50 | 148.3 [1] |
| Acrylamide | IC50 | 938.0 [1] |
| Nintedanib | IC50 | 610.0 [1] |
| Nintedanib esylate | IC50 | 610.0 [1] |
| Ponatinib | IC50 | 7.1 [1] |
| Ceritinib | IC50 | 950.0 [1] |
| Doramapimod | IC50 | 7000.0 [1] |
| Nvp-aew541 | IC50 | 5000.0 [1] |
| Erdafitinib | IC50 | 6.61 [1] |
| 3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide | IC50 | 500.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| 1-[2-Amino-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea | IC50 | 560.0 [1] |
| CID 118295624 | IC50 | 19.3 [1] |
| CID 44814409 | IC50 | 10000.0 [1] |
| Roblitinib | IC50 | 1.9 [1] |
| 6H-Purin-6-one, 2-amino-1,7-dihydro-8-phenyl- | IC50 | 20000.0 [1] |
| cis-3-[4-Amino-7-(3-azetidin-1-ylmethyl-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-phenol | IC50 | 2800.0 [1] |
| 7-[3-(Azetidin-1-ylmethyl)cyclobutyl]-5-[3-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 10000.0 [1] |
| N-[4-[[3-(3,5-Dimethoxyphenyl)-7-[4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]methyl]phenyl]prop-2-enamide | IC50 | 32.0 [1] |
| 6-[2-[(E)-2-[4-(Morpholin-4-ylmethyl)phenyl]ethenyl]pyridin-4-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one | IC50 | 10000.0 [1] |
| CID 46864270 | IC50 | 34.0 [1] |
| Ethyl 8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carboxylate | IC50 | 10000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| 7,8-Dichloro-9-methyl-1-oxospiro[2,4-dihydropyrido[3,4-b]indole-3,4'-piperidine]-4-carbonitrile | IC50 | 10000.0 [1] |
| N-(3-Imidazo[1,2-b]pyridazin-6-yloxyphenyl)-3-(trifluoromethyl)benzamide | IC50 | 10000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 2-[3-[[4-[(2,2-Difluoro-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-fluoropyrimidin-2-yl]amino]phenoxy]-N-methylacetamide | Ki | 217.0 [1] |
| 2-[3-(3-Piperidin-4-ylpropoxy)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 2000.0 [1] |
| 2-[3-(Methanesulfonamido)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 2000.0 [1] |
| 1-[3-[8-(Pyridin-4-ylmethylamino)imidazo[1,2-a]pyrazin-6-yl]phenyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 50000.0 [1] |
| 4-[6-(Benzylamino)imidazo[1,2-B]pyridazin-3-Yl]benzonitrile | IC50 | 5900.0 [1] |
| 6-[(2r)-2-(3-Fluorophenyl)pyrrolidin-1-Yl]-3-(Pyridin-2-Yl)imidazo[1,2-B]pyridazine | IC50 | 9200.0 [1] |
| 2-[4-[4-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperazin-1-yl]acetic acid | IC50 | 5300.0 [1] |
| 1-[4-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperidin-4-ol | IC50 | 4400.0 [1] |
| N-[(3R,4S)-4-[[5-[(2,6-Difluoro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]oxolan-3-yl]prop-2-enamide | IC50 | 13.0 [1] |
| N-[2-[[5-[(2,6-Difluoro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-3-methylphenyl]prop-2-enamide | IC50 | 3.0 [1] |
| N-[2-[[5-[(2,6-Difluoro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-5-(4-ethylpiperazin-1-yl)-3-methylphenyl]prop-2-enamide | IC50 | 4.0 [1] |
| N-[2-[[5-[(2,6-Difluoro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]phenyl]prop-2-enamide | IC50 | 8.0 [1] |
| 4-Chloro-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(5-morpholin-4-ylpyridin-3-yl)ethynyl]benzamide | IC50 | 5.5 [1] |
| 7-(1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazin-2-yl)-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]quinazolin-4-amine | IC50 | 52.7 [1] |
| Clk1-IN-1 | IC50 | 10000.0 [1] |
| [5-Amino-1-(2-chloro-5-hydroxyphenyl)pyrazol-4-yl]-(3-methylphenyl)methanone | IC50 | 4100.0 [1] |
| 5-[5-Amino-4-(1H-indole-2-carbonyl)pyrazol-1-yl]-1,3-dihydrobenzimidazol-2-one | IC50 | 50000.0 [1] |
| [5-Amino-1-(2-chlorophenyl)pyrazol-4-yl]-(1H-indol-2-yl)methanone | IC50 | 3100.0 [1] |
| [5-Amino-1-(1H-indol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone | IC50 | 110.0 [1] |
| [5-Amino-1-(2-chloro-5-hydroxyphenyl)pyrazol-4-yl]-quinolin-6-ylmethanone | IC50 | 740.0 [1] |
| [5-Amino-1-(2-chloro-5-hydroxyphenyl)pyrazol-4-yl]-(1H-indol-2-yl)methanone | IC50 | 200.0 [1] |
| [5-Amino-1-(2-methyl-1H-indol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone | IC50 | 85.0 [1] |
| [5-Amino-1-(2-chloro-5-hydroxyphenyl)pyrazol-4-yl]-[5-(morpholin-4-ylmethyl)-1H-indol-2-yl]methanone | IC50 | 160.0 [1] |
| [5-Amino-1-(2-chloro-5-hydroxyphenyl)pyrazol-4-yl]-(1-benzofuran-2-yl)methanone | IC50 | 730.0 [1] |
| N-[2-[[5-[(3,5-Dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-3-methylphenyl]prop-2-enamide | IC50 | 188.0 [1] |
| N-[3-Chloro-2-[[5-[(2,6-dichloro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]phenyl]prop-2-enamide | IC50 | 3.8 [1] |
| N-[2-[[5-[(2,6-Dichloro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-3-(trifluoromethyl)phenyl]prop-2-enamide | IC50 | 24.9 [1] |
| N-[2-[[5-[(2,6-Dichloro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-3-methoxyphenyl]prop-2-enamide | IC50 | 4.8 [1] |
| N-[3,5-Dichloro-2-[[5-[(2,6-dichloro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]phenyl]prop-2-enamide | IC50 | 8.5 [1] |
| N-[3-Chloro-2-[[5-[(2,6-dichloro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-5-fluorophenyl]prop-2-enamide | IC50 | 2.6 [1] |
| N-[2-[[5-[(2,6-Dichloro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]-3-fluorophenyl]prop-2-enamide | IC50 | 5.3 [1] |
| N-[2-[[5-[1-(2,6-Dichloro-3,5-dimethoxyphenyl)ethoxy]pyrimidin-2-yl]amino]-3-methylphenyl]prop-2-enamide | IC50 | 10000.0 [1] |